Skip to content

Distal Tibia Sarcoma Treatment Using Allograft Arthrodesis of the Ankle

Distal Tibia Sarcoma Treatment Using Allograft Arthrodesis of the Ankle

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03129672
Enrollment
20
Registered
2017-04-26
Start date
2014-05-20
Completion date
2019-08-31
Last updated
2019-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Neoplasm

Keywords

allograft, distal tibia sarcoma

Brief summary

The study show the clinical results of limb salvage for primary malignant bone tumor of the distal tibia using block excision of the tumor and reconstruction with allograft arthrodesis with different methods of fixation (plates or intramedullary nail system)

Detailed description

It is well known that before the 1980's the usual treatment for the sarcomas of the distal tibia was amputation (1). Currently, however, after the improvement of the chemotherapy treatments, potential reconstructions of the area in well studied patients are possible, and for that we have a wide range: auto graft, allograft and prosthetic reconstructions (2, 3) Is important to know that osteosarcoma still meant the principal diagnosis, followed by the Ewing sarcoma and synovial sarcoma, but their malignant potency is lower than when they are present in the rest of the body (4, 5, and 6) The purpose of this study is to recollect the patients' data followed from different institutions and countries that have the criteria for their inclusion in the study (primary malignant bone tumor of the distal tibia that underwent block excision of the tumor and reconstruction with allograft arthrodesis from the patient management for any of the multidisciplinary sarcoma team including in this study).

Interventions

PROCEDUREallograft arthrodesis of ankle

patients that underwent trought a block resection of a malignant tumor of the distal tibia and reconstruction with allograft arthrodesis

Sponsors

Hospital del Niño Dr. José Renán Esquivel
CollaboratorOTHER
Patricia Bonilla
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

\- all patients with histopathologyc diagnosis of a primary malignant bone tumor at the distal tibia that went through a tumor resection and received reconstruction with allograft as first surgical treatment

Exclusion criteria

* none histopatologic proved diagnosis * patients that received other kind of surgical treatment

Design outcomes

Primary

MeasureTime frameDescription
principal diagnosis of the patients that wen trough ankle after resection of a primary malignant tumor of the distal tibia1 monthosteosarcoma: 5 patientas (2 females of 18 and 15 years old and 3 males of 19, 24 and 16 years old) telangiectasic osteosarcoma (1 female of 21 years old) Ewing sarcoma (1 male of 33 years old)

Secondary

MeasureTime frameDescription
mobility5 month to 10 years follow upsurgical site infection, non union, malunion, osteosynthesis material failure
mortality5 months to 10 years follow upsecundary of the primary tumor diagnosis or metastatic disease of it
MSTS SCORE5 month to 10 years follow uptotal points score of the msts score at the final follow up

Countries

Panama

Contacts

Primary Contactpatricia bonilla, MD
patibh_8@hotmail.com, patriciabonillah@gmail.com+507-5129813
Backup ContactJorge Navia, MD
jorgenaviagiraldo@gmail.com, oncologiaortopedica@emcali.net.co+57-3155643400

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026